Page last updated: 2024-08-17

galactose and atorvastatin

galactose has been researched along with atorvastatin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gassman, J; Gipson, D; Greene, T; Joy, M; Pinsk, M; Savin, V; Somers, M; Trachtman, H; Vento, S; Wickman, L	1
Allahtavakoli, M; Fatemi, I; Kaeidi, A; Kaviani, E; Mozafari, N; Rahmani, M; Shamsizadeh, A	1
Diril, M; Karasulu, HY; Türkyılmaz, GY	1

Trials

1 trial(s) available for galactose and atorvastatin

Article	Year
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. BMC nephrology, 2011, Feb-10, Volume: 12 Topics: Adalimumab; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Galactose; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Humans; Infant; Lisinopril; Losartan; Middle Aged; Pyrroles; Treatment Outcome; Young Adult	2011

Article

Year

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design.

BMC nephrology, 2011, Feb-10, Volume: 12

Topics: Adalimumab; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Galactose; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Humans; Infant; Lisinopril; Losartan; Middle Aged; Pyrroles; Treatment Outcome; Young Adult

2011

Other Studies

2 other study(ies) available for galactose and atorvastatin

Article	Year
Protective effect of atorvastatin on d-galactose-induced aging model in mice. Behavioural brain research, 2017, 09-15, Volume: 334 Topics: Aging; Animals; Antioxidants; Anxiety; Atorvastatin; Brain; Brain-Derived Neurotrophic Factor; Cognition; Dose-Response Relationship, Drug; Galactose; Male; Maze Learning; Mice; Models, Animal; Nootropic Agents; Random Allocation; Recognition, Psychology; Superoxide Dismutase	2017
Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System Containing Atorvastatin Calcium. Current drug delivery, 2019, Volume: 16, Issue:8 Topics: Atorvastatin; Caco-2 Cells; Drug Compounding; Drug Delivery Systems; Emulsions; Ethanol; Hexoses; Humans; Lipids; Oleic Acid; Particle Size; Polysorbates; Solubility; Surface Properties; Surface-Active Agents; Tumor Cells, Cultured	2019

Article

Year

Protective effect of atorvastatin on d-galactose-induced aging model in mice.

Behavioural brain research, 2017, 09-15, Volume: 334

Topics: Aging; Animals; Antioxidants; Anxiety; Atorvastatin; Brain; Brain-Derived Neurotrophic Factor; Cognition; Dose-Response Relationship, Drug; Galactose; Male; Maze Learning; Mice; Models, Animal; Nootropic Agents; Random Allocation; Recognition, Psychology; Superoxide Dismutase

2017

Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System Containing Atorvastatin Calcium.

Current drug delivery, 2019, Volume: 16, Issue:8

Topics: Atorvastatin; Caco-2 Cells; Drug Compounding; Drug Delivery Systems; Emulsions; Ethanol; Hexoses; Humans; Lipids; Oleic Acid; Particle Size; Polysorbates; Solubility; Surface Properties; Surface-Active Agents; Tumor Cells, Cultured

2019